Accelerate to discover
Related topics
Low-dose imaging in a new preclinical total-body PET/CT scanner
Jun 12, 2019
Ionizing radiation constitutes a health risk to imaging scientists and study animals. Both PET and CT produce ionizing...
Fluxion Biosciences and National Cancer Institute cooperate to validate IsoFlux for sequencing
Jun 12, 2019
Fluxion with IsoFlux has partnered with the Cleveland Clinic. They are aiming to improve sensitivity by timing the...
New insight into Cas9 off-target activity
Jun 7, 2019
Scientists at the MRC London Institute of Medical Sciences and AstraZeneca studied how CRISPR-Cas9 differentiates...
IncuCyte virtual event: Dimension of time - from culture to assay
Jun 5, 2019
This event offers an overview of how live-cell analysis enables real-time analysis for the full workflow of the cells....
Join the AVANCE Track & Keep your MRI on Track
Jun 4, 2019
Your research depends on the scientific advances that you make with your MRI instrument. Take your instrument and your...
A novel method for isolating high-quality UHMW DNA from animal and human tissues
May 31, 2019
New isolation protocol for isolating high-quality UHMW DNA from 10 mg of freshly frozen or liquid-preserved animal and...
Assessment of myocardial dynamics using photoacoustics & cardiac elastography
May 17, 2019
Are you interested in Principles of Photoacoustic (PA) Imaging, and its application in cardiovascular research? Don’t...
Webinar recording: Detecting cancer-associated structural variants using Bionano optical maps
May 15, 2019
Bionano’s genome mapping technology directly observes long molecules from 150,000 bp to megabase pair lengths to...
Mar 22, 2016
The mutations driving cancer create clonal populations that differ not just between cancer patients, but within individual tumors. These mutations contain small but significant populations which may survive treatment and metastasize. The only method to get a complete picture of tumor clonality is by sequencing single cells.
In this webinar, you will learn how you can make breakthrough discoveries in your research using single-cell DNA Sequencing. Dr. Ioannis Ragoussis of McGill University will share his research using single-cell whole exome sequencing to reveal the true heterogeneity and cell lineages present in triple negative breast cancer.
Brand profile
Fluidigm is a Molecular and Single Cell Biology company that creates microfluidic-based chips and instrumentation for Life-Science research.
More info at:
www.fluidigm.com/
BioFocus newsletter
Register to receive Brand new technology development, Important product updates, Interesting scientific events and more!
BioTech a.s. © 2014
Designed & developed by imagineit
Technologies
